<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="576">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02026193</url>
  </required_header>
  <id_info>
    <org_study_id>RMB-0439-13</org_study_id>
    <nct_id>NCT02026193</nct_id>
  </id_info>
  <brief_title>IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The chances to achieve pregnancy after retrieving &gt;15 oocytes are not good, probably because
      of bad effect on the endometrium (uterine inner lining). Therefore, in most such cases the
      investigators prefer to freeze all embryos, and transfer in a thaw cycle. With the
      introduction of oocyte vitrification (very fast cooling) technology, a new option emerged:
      to freeze un-fertilized eggs, to be fertilized and used later in a thaw cycle.

      The purpose of this study is to compare the outcome of these two approaches.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fetal Heart Activity 1 Month Post Embryo Transfer</measure>
    <time_frame>1 month after embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Fetal heart activity as demonsrated by vaginal ultrasound 1 month post embryo transfer</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>oocyte vitrification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All retrieved mature oocytes will be vitrified.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>embryo freezing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All retrieved oocytes will be fertilized, and resulting embryos will be frozen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>oocyte vitrification</intervention_name>
    <arm_group_label>oocyte vitrification</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>embryo freezing</intervention_name>
    <arm_group_label>embryo freezing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IVF patients

          -  ovulation trigger with Decapeptyl 0.2 mg because of ovarian hyper-response: E2 on
             trigger day .12,000 pmol/l and/or &gt;15 oocytes.

          -  Normal uterus

        Exclusion Criteria:

          -  &lt;20% fertilization rate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IVF Unit, Rambam medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011 Oct;26(10):2593-7. doi: 10.1093/humrep/der251. Epub 2011 Aug 9. Review.</citation>
    <PMID>21828116</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <lastchanged_date>May 20, 2015</lastchanged_date>
  <firstreceived_date>December 30, 2013</firstreceived_date>
  <firstreceived_results_date>April 29, 2015</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Shahar Kol MD</investigator_full_name>
    <investigator_title>Director, IVF Unit</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Oocyte Vitrification</title>
          <description>All retrieved mature oocytes will be vitrified.
oocyte vitrification</description>
        </group>
        <group group_id="P2">
          <title>Embryo Freezing</title>
          <description>All retrieved oocytes will be fertilized, and resulting embryos will be frozen.
embryo freezing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oocyte Vitrification</title>
          <description>All retrieved mature oocytes will be vitrified.
oocyte vitrification</description>
        </group>
        <group group_id="B2">
          <title>Embryo Freezing</title>
          <description>All retrieved oocytes will be fertilized, and resulting embryos will be frozen.
embryo freezing</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="29.6" spread="5.5"/>
                <measurement group_id="B2" value="25" spread="2.6"/>
                <measurement group_id="B3" value="28.3" spread="5.2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Israel</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fetal Heart Activity 1 Month Post Embryo Transfer</title>
        <description>Fetal heart activity as demonsrated by vaginal ultrasound 1 month post embryo transfer</description>
        <time_frame>1 month after embryo transfer</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Oocyte Vitrification</title>
            <description>All retrieved mature oocytes will be vitrified.
oocyte vitrification</description>
          </group>
          <group group_id="O2">
            <title>Embryo Freezing</title>
            <description>All retrieved oocytes will be fertilized, and resulting embryos will be frozen.
embryo freezing</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3"/>
                  <measurement group_id="O2" value="8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Fetal Heart Activity 1 Month Post Embryo Transfer</title>
            <description>Fetal heart activity as demonsrated by vaginal ultrasound 1 month post embryo transfer</description>
            <units>participants with fetal heart activity</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Oocyte Vitrification</title>
          <description>All retrieved mature oocytes will be vitrified.
oocyte vitrification</description>
        </group>
        <group group_id="E2">
          <title>Embryo Freezing</title>
          <description>All retrieved oocytes will be fertilized, and resulting embryos will be frozen.
embryo freezing</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Shahar Kol , Director IVF Unit</name_or_title>
      <organization>Rambam health Care campus</organization>
      <phone>97247773232</phone>
      <email>skol@rambam.health.gov.il</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
